Please wait while the formulary information is being retrieved.
DALIRESP (ROFLUMILAST)
- Prevention of bronchospasm with chronic bronchitis
250 mcg tablet
- 1 tablet (250 mcg) by oral route once daily for 4 weeks
500 mcg tablet
- 1 tablet (500 mcg) by oral route once daily
Prevention of bronchospasm with chronic bronchitis
- 1 tablet (250 mcg) by oral route once daily for 4 weeks
- 1 tablet (250 mcg) by oral route once daily
- 2 tablets (500 mcg) by oral route once daily
- 1 tablet (500 mcg) by oral route once daily
- None
Contraindicated
- None
Severe
Moderate
- Belladonna-phenobarbital
- carbamazepine
- Carbatrol
- Cerebyx
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Donnatal
- enzalutamide
- Epitol
- Equetro
- fosphenytoin
- isoniazid-rifamp-pyrazinamide
- Luminal
- Mysoline
- phenobarb-hyoscy-atropine-scop
- phenobarbital
- phenobarbital sodium
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- primidone
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- Rifater
- Tegretol
- Tegretol Xr
- Xtandi
- None
Contraindicated
- Depression
- Suicidal
- Suicidal ideation
Severe
Moderate
- Weight loss
DALIRESP (ROFLUMILAST)
- Prevention of bronchospasm with chronic bronchitis
- None
- Back pain
- Diarrhea
- Headache disorder
- Nausea
- Weight loss
More Frequent
Severe
Less Severe
- None
- Acute abdominal pain
- Anorexia
- Dizziness
- Dyspepsia
- Gastritis
- Influenza
- Insomnia
- Muscle spasm
- Rhinitis
- Sinusitis
- Symptoms of anxiety
- Tremor
- Urinary tract infection
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Angioedema
- Suicidal
- Suicidal ideation
Less Severe
- Depression
- Gynecomastia
- Skin rash
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Roflumilast
No safety and efficacy. Not studied in pediatrics, indicated for COPD.
- 1 Day – 18 Years
- No safety and efficacy. Not studied in pediatrics, indicated for COPD.
Roflumilast
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Roflumilast
Insufficient human data; excreted in rats; manufacturer does not recommend
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data; excreted in rats; manufacturer does not recommend |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Prevention of bronchospasm with chronic bronchitis | |
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| 0-9 | A-Z |
|---|---|
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
Formulary Reference Tool